Louisville, KYNCT07659626Now EnrollingIRB Ready

Dry Eye Clinical Trial in Louisville, KY

Access cutting-edge dry eye treatment through this clinical trial at a research site in Louisville. Study-provided care at no cost to qualified participants.

Sponsored by The Eye Care Institute

Quick Self-Assessment

See if you qualify for this Louisville location

Preparing your pre-screening questions…

Expert Care in Louisville

Access dry eye specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dry eye treatment provided free

Apply for This Louisville Location

Check if you qualify for this dry eye clinical trial in Louisville, KY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Louisville

    Convenient for KY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Louisville site if eligible
  4. 4Begin participation

About This Dry Eye Study in Louisville

This is a prospective, longitudinal, single-center study designed to evaluate the long-term changes in symptoms and tear production in subjects with dry eye disease. The study is randomized and investigator-masked, with subjects assigned to either the TRYPTYR (Acoltremon ophthalmic solution 0.003%) arm or the control arm (Refresh Classic Preservative-free). The study will be conducted at a single site, with subjects undergoing assessments at baseline and at months 1, 3, 6, 9, and 12.

Sponsor: The Eye Care Institute

Who Can Participate

Inclusion Criteria

Male or female, 18 years of age or older at the Screening visit.
Have a previous history of DED, clinician diagnosed, or patient reported, within the previous 6 months prior to the Screening visit.
Have used, and/or desired to use artificial tears for DED symptoms within 2 months prior to the Screening visit.
Both of the following signs of DED in the same eye:
Total corneal fluorescein staining score of \>= 2 and \<= 10 based on the NEI grading scheme, with no one region scoring \> 3 in at least 1 eye.
Unanesthetized Schirmer test score \>= 2 and \< 10 mm/5 min in at least 1 eye.
If both eyes qualify, the eye with the lower baseline Schirmer score will be the study eye (If the Schirmer score is the same, the right eye will be the study eye).
Symptomatic defined as an ODS-VAS score of \>=40.
Corrected visual acuity equal to or better than logMar +0.7 (Snellen equivalent equal to or better than 20/100), as assessed by Early Treatment of Diabetic Retinopathy Study (ETDRS) scale in both eyes.
Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.
Written informed consent from the subject has been obtained prior to any study related procedures.
Able, as assessed by the investigator, and willing to follow study instructions and likely to complete all required study visits.

Exclusion Criteria

History or presence of any ocular disorder or condition (other than DED) in either eye that would, in the opinion of the investigator, interfere with the interpretation of the study results or subject safety.
Diagnosis of recurrent, ongoing, or active ocular infection.
History of ocular surgery within 1 year prior to the Screening visit.
Have had a corneal transplant in either or both eyes.
Use of contact lenses within 2 hours of any study visit.
Use of lid heating therapy or Meibomian gland probing/therapeutic expression within 1 year prior to the Screening visit.
Use of artificial tears within 24 hours of Screening visit.
Use of any topical ocular anti-inflammatory medication or dry eye pharmaceuticals within 30 days prior to the Screening visit.
Use of any topical ocular glaucoma medication within 30 days prior to the Screening visit.
Change in use of any other topical ocular medication within 14 days prior to the Screening visit.
Use of medications for the treatment of severe DED and/or Meibomian gland disease within 30 days prior to the Screening visit.
Initiation, discontinuation, or change in dose of a systemic medication known to cause ocular drying less than 14 days prior to the Screening visit.
Use of a systemic corticosteroid less than 30 days prior to the Screening visit.
Use of a systemic immunomodulator within 30 days prior to the Screening visit.
Use of an investigational product or device within 30 days prior to the Screening visit.
At the Screening visit, have uncontrolled or severe systemic allergy, rhinitis or sinusitis.
History or presence of significant systemic disease.
Known allergies or sensitivity to the study interventions or study diagnostic agents.
Women of childbearing potential who are not using a medically acceptable form of birth control.
The subject has a condition or is in a situation that, in the Investigator's opinion, may put the subject at significant risk.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Louisville?

Yes, this clinical trial (NCT07659626) has an active research site in Louisville, KY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dry Eye Treatment Options in Louisville, KY

If you're searching for dry eye treatment options in Louisville, KY, this clinical trial (NCT07659626) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Louisville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dry eye specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dry eye clinical trials near you to find additional studies recruiting in your area.

More Sjogrens Syndrome Trials in Louisville, KY

See all sjogrens syndrome clinical trials recruiting in Louisville — not just this study.

Browse Sjogrens Syndrome Trials in Louisville →

Browse More Trials by Condition

Sjogrens Syndrome TrialsDry Eye TrialsAll Conditions →

Ready to Join in Louisville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Louisville, KY